SelfDecode - About the company
SelfDecode is a series A company based in San Luis Obispo (United States), founded in 2016 by Puya Yazdi and Joseph Cohen. It operates as a Provider of personal genome analysis service. SelfDecode has raised $8M in funding, with a current valuation of $*****. The company has 178 active competitors, including 28 funded and 13 that have exited. Its top competitors include companies like 23andMe, Helix and Color.
Company Details
Provider of personal genome analysis service. Genome sequence data can be uploaded by the user from other services, which is then analyzed on SelfCode's servers to generate a variant report. The software platform also provides tools to enable the user to prepare customized reports and look at the consequences of their mutations, in terms of overall health, wellness, and more.
- Website
- selfdecode.com
- Email ID
- *****@selfdecode.com
- Registered Address
- 500 MOLINO STREET, UNIT #105, LOS ANGELES, CA
Key Metrics
Founded Year
2016
Location
San Luis Obispo, United States
Stage
Series A
Total Funding
$8M in 1 round
Latest Funding Round
Post Money Valuation
$***** as on May 12, 2025
Investors
Ranked
10th among 178 active competitors
Annual Revenue
$1M - $10M as on Dec 31, 2023
Employee Count
15 as on Jan 23, 2025
Similar Companies
Legal entities associated with SelfDecode
SelfDecode is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Genius Labs Co CIN: 0001860029 , United States, Active | $1M - $10M (As on Dec 31, 2023) | 15 (As on Jan 23, 2025) | - |
Sign up to download SelfDecode's company profile
SelfDecode's funding and investors
SelfDecode has raised a total funding of $8M over 1 round. Its latest funding round was a Series A round on Nov 16, 2021 for $*****. 2 investors participated in its latest round. SelfDecode has 1 institutional investor and 2 angel investors.
Here is the list of recent funding rounds of SelfDecode:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 16, 2021 | 6807072 | Series A | 6374863 | 2102303 | 7817000 | 5320517 |
View details of SelfDecode's funding rounds and investors
SelfDecode's founders and board of directors
Founder? Claim ProfileThe founders of SelfDecode are Puya Yazdi and Joseph Cohen.
Here are the details of SelfDecode's key team members:
- Puya Yazdi: Co-Founder – Chief Science Officer & Chief Medical Officer ➤Advanced Genomics & AI of SelfDecode and founder of 2 other companies, Puya Yazdi - Co-Founder and ABOPM.
- Joseph Cohen: Co-Founder & CEO of SelfDecode. Contact Info: 1 email address
View details of SelfDecode's Founder profiles and Board Members
SelfDecode's employee count trend
SelfDecode has 15 employees as of Jan 25. Here is SelfDecode's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
SelfDecode's Competitors and alternates
Top competitors of SelfDecode include 23andMe, Helix and Color. Here is the list of Top 10 competitors of SelfDecode, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | 23andMe 2006, Sunnyvale (United States), Acquired | Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | $944M | 77/100 | |
2nd | Helix 2015, San Francisco (United States), Series E | Provider of a genomic database for clinical research | $435M | 71/100 | |
3rd | Color 2013, Burlingame (United States), Series E | Provider of end-to-end Virtual clinic offering cancer-based solutions | $491M | 66/100 | |
4th | Nucleus Genomics 2021, Manhattan (United States), Series A | Provider of genetic testing kits for rare variant analysis | $32M | 62/100 | |
5th | MyOme 2017, San Carlos (United States), Series B | Provider of a platform for gene analysis to determine genetic diseases and drug response | $36M | 60/100 | |
6th | Genomind 2009, King Of Prussia (United States), Series C | Developer of genetic tests for personalised medicines to enhance mental health treatment | $64.4M | 56/100 | |
7th | Veritas Genetics 2014, Danvers (United States), Acquired | Provider of genetic testing products | $53.4M | 55/100 | |
8th | Segterra (InsideTracker) 2009, Cambridge (United States), Series B | Personalized path for health, wellness, and performance applications | $17.5M | 54/100 | |
9th | Counsyl 2007, San Francisco (United States), Acquired | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | $113M | 54/100 | |
10th | SelfDecode 2016, San Luis Obispo (United States), Series A | Provider of personal genome analysis service | $8M | 50/100 |
Looking for more details on SelfDecode's competitors? Click here to see the top ones
SelfDecode's Investments and acquisitions
SelfDecode has made no investments or acquisitions yet.
Reports related to SelfDecode
Here is the latest report on SelfDecode's sector:
News related to SelfDecode
•
Revolutionizing Precision Health with AI: SelfDecode Unveils Groundbreaking Precision Health GPTPR Newswire•Jul 03, 2024•SelfDecode
•
•
SelfDecode Quietly Raises $2M as it Steps Up Polygenic Risk Scoring EffortsGenomeWeb•Jun 01, 2023•SelfDecode, Wefunder
•
SelfDecode Moves Into B2B Services as it Seeks to Diversify, Increase its ReachGenomeWeb•Dec 04, 2021•SelfDecode
•
•
Are you a Founder ?
FAQs about SelfDecode
Explore our recently published companies
- TRAINCONST - Chennai based, 2001 founded, Unfunded company
- Turbo Magic - Kyiv based, Unfunded company
- Comportal - Kazakhstan based, Unfunded company
- Brisk Business - 2013 founded, Unfunded company
- Istok Audio - Unfunded company
- SP SEARCH - Issy-les-Moulineaux based, 2003 founded, Unfunded company